The US FDA has delayed its review of Novo Nordisk's hemophilia A treatment denecimig, citing ongoing issues at a manufacturing facility. The Danish company aims for a US launch in 2027 pending FDA ...
Novartis has entered a licensing deal worth up to $7.8 billion with Chinese biotech firm Abogen to develop mRNA-based therapies, focusing on autoimmune diseases. This strategic move highlights ...
Summit Therapeutics partners with AstraZeneca and Daiichi Sankyo to conduct a late-stage clinical trial of their cancer drugs in multiple tumor types, including triple-negative breast cancer.
Sanofi has entered a major partnership with Regeneron to collaborate on four late-stage antibody candidates targeting Type 2 ...
India should join ICH, restore Weighted R&D tax deduction to drive Innovation: Zydus’ Pankaj Patel
Pankaj Patel, Chairman of Zydus Lifesciences, emphasizes the need for India to join the International Council for ...
Sun Pharma's Leqselvi demonstrates lasting hair regrowth for over two years in a long-term trial for alopecia areata, with a ...
The Indian central drug regulator, CDSCO, abandons plans for a digital platform to publicly disclose drug test reports due to a lack of consensus and concerns over verification and regulatory ...
Foghorn Therapeutics announces the termination of its cancer drug partnership with Eli Lilly following disappointing trial ...
Regeneron's innovative drug Trevogrumab effectively reduces muscle mass loss by 50% compared to semaglutide alone in a major ...
Florida Attorney General James Uthmeier has filed a lawsuit against Pfizer and its CEO, alleging misleading claims about the ...
Karnataka Government highlights extreme price disparities in cancer treatment drugs, seeking national intervention to protect ...
A new real-world study reveals that patients switching from weight-loss injections to Novo Nordisk's Wegovy pill experience ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results